The effects of masculinisation through hormone therapy, particularly testosterone, on the skeleton can vary depending on several factors, including age and the timing of treatment in relation to the closure of growth plates (epiphyseal plates) in the bones. The potential effects in both scenarios:
- **Increased Bone Density**: Testosterone can lead to an increase in bone density. This effect can be beneficial for bone health, reducing the risk of osteoporosis and fractures in the long term.
- **Potential Growth**: Testosterone may contribute to continued linear growth in height and limb length, although the extent of this effect varies among individuals.
- **Bone Development**: Masculinising hormone therapy can influence the development of bone structure, leading to a more robust and masculine bone morphology.- **Increased Bone Density**: Similar to pre-pubertal individuals, testosterone therapy can result in increased bone density, promoting bone health.
- **No Height Increase**: After epiphyseal plate fusion, there is no potential for further linear growth in height as the growth plates are closed.
- **Bone Remodeling**: Testosterone can influence bone remodeling, potentially increasing bone mass and strength, particularly in weight-bearing bones like the hips and spine.It’s essential to note that the effects on bone density and bone structure are generally positive and can contribute to overall bone health in individuals undergoing masculinising hormone therapy. There will, of course, be some individual variability in the extent of these changes.
A healthy lifestyle that includes weight-bearing exercises, a balanced diet rich in calcium and vitamin D, and avoidance of smoking and excessive alcohol can support bone health during and after masculinisation.
Individuals considering hormone therapy should be aware of the potential skeletal effects s they can make make informed decisions and ensure their overall wellbeing.